News Headline Summary

Amgen (AMGN) says its working with FDA on Sensipar development

Reaction details (01:16)

- No immediate reaction seen in Co. shares, traded last USD 89.29 (-0.29%)

27 Feb 2013 - 01:15 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: